Cytokine gene expression patterns associated with immunization against Marek's disease in chickens

Vaccine

Volumn 25, Issue 3, 2007, Pages 424-432

  Abdul Careem, Mohamed Faizal ^a   Hunter, Bruce D ^a   Parvizi, Payvand ^a   Haghighi, Hamid R ^a   Thanthrige Don, Niroshan ^a   Sharif, Shayan ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Chicken immunology; Cytokine; Marek's disease virus; Protection; Real time PCR; Vaccine

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 6; MAREK DISEASE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BIRD DISEASE; CHICKEN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEATHER; GENE EXPRESSION; GENOME; IMMUNIZATION; IMMUNOMODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; TURKEY (BIRD); VACCINATION; VIRUS TRANSMISSION;

ANIMALS; CHICKENS; CYTOKINES; DATA INTERPRETATION, STATISTICAL; DNA PRIMERS; DNA, VIRAL; FEATHERS; GENE EXPRESSION REGULATION; HERPESVIRUS 2, GALLID; LYMPHOID TISSUE; MAREK DISEASE; MAREK DISEASE VACCINES; NITRIC OXIDE SYNTHASE TYPE II; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SPLEEN;

EID: 33845198479     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.08.006     Document Type: Article

References (48)

1. Abdul-Careem M.F., Hunter B.D., Nagy E., Read L.R., Sanei B., Spencer J.L., et al. Development of a real-time PCR assay using SYBR Green chemistry for monitoring Marek's disease virus genome load in feather tips. J Virol Methods 133 1 (2006) 34-40
2. Abdul-Careem M.F., Hunter B.D., Sarson A.J., Mayameei A., Zhou H., and Sharif S. Marek's disease virus-induced transient paralysis is associated with cytokine gene expression in the nervous system. Viral Immunol 19 2 (2006) 167-176
3. Baigent S.J., and Davision F. Marek's disease virus: biology and life cycle. In: Davision F., and Nair V. (Eds). Marek's disease, an evolving problem (2004), Elsevier Academic Press, Great Britain 62-77
4. Belkaid Y., Hoffmann K.F., Mendez S., Kamhawi S., Udey M.C., Wynn T.A., et al. The role of IL-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti IL-10 receptor antibody for sterile cure. J Exp Med 194 10 (2001) 1497-1506
5. Belkaid Y., Piccirillo C.A., Mendez S., Shevach E.M., and Sacks D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420 6915 (2002) 502-507
6. Biggs P.M. The Leeuwenhoek Lecture, 1997. Marek's disease herpesvirus: oncogenesis and prevention. Philos Trans R Soc Lond B Biol Sci 352 1364 (1997) 1951-1962
7. Burgess S.C., Basaran B.H., and Davison T.F. Resistance to Marek's disease herpesvirus-induced lymphoma is multiphasic and dependent on host genotype. Vet Pathol 38 2 (2001) 129-142
8. Calnek B.W. Pathogenesis of Marek's disease virus infection. In: Hirai K. (Ed). Current topics in microbiology and immunology 255 (2001), Springer, Berlin 25-54
9. Calnek B.W., and Witter R.L. Marek's disease. In: Calnek B.W. (Ed). Diseases of poultry (1997), Iowa State University Press, Ames, IA 369-413
10. Davison T.F. The immunologists' debt to the chicken. Br Poult Sci 44 1 (2003) 6-21
11. Djeraba A., Bernadet N., Dambrine G., and Quere P. Nitric oxide inhibits Marek's disease virus replication but is not the single factor in interferon-gamma-mediated viral inhibition. Virology 277 1 (2000) 58-65
12. Djeraba A., Musset E., Bernadet N., Vern Y.L., and Quere P. Similar pattern of iNOS expression, NO production and cytokine response in genetic and vaccination-acquired resistance to Marek's disease. Vet Immunol Immunopathol 85 1-2 (2002) 63-75
13. Endharti A.T., Rifa'I M., Shi Z., Fukuoka Y., Nakahara Y., Kawamoto Y., et al. CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-γ production and proliferation of CD8+ T cells. J Immunol 175 11 (2005) 7093-7097
14. Garcia-Camacho L., Schat K.A., Brooks R. Jr., and Bounous D.I. Early cell-mediated immune responses to Marek's disease virus in two chicken lines with defined major histocompatibility complex antigens. Vet Immunol Immunopathol 95 3-4 (2003) 145-153
15. Gimeno I.M., Witter R.L., Hunt H.D., Reddy S.M., and Reed W.M. Biocharacteristics shared by highly protective vaccines against Marek's disease. Avian Pathol 33 1 (2004) 59-68
16. Göbel T.W., Schneider K., Schaerer B., Meiri I., Puehler F., Weigend S., et al. IL-18 stimulates the proliferation and IFN-gamma release of CD4+ T cells in the chicken: conservation of a Th1-like system in a nonmammalian species. J Immunol 171 4 (2003) 1809-1815
17. Heller E.D., and Schat K.A. Enhancement of natural killer cell activity by Marek's disease vaccines. Avian Pathol 16 1 (1987) 51-60
18. Islam A., Cheetham B.F., Mahony T.J., Young P.L., and Walkden-Brown S.W. Absolute quantitation of Marek's disease virus and herpesvirus of turkeys in chicken lymphocyte, feather tip and dust samples using real-time PCR. J Virol Methods 132 1-2 (2006) 127-134
19. Johnston P.A., Liu H., O'Connell T., Phelps P., Bland M., Tyczkowski J., et al. Applications in ovo technology. Poult Sci 76 1 (1997) 165-178
20. Jarosinski K.W., Njaa B.L., O'connell P.H., and Schat K.A. Pro-inflammatory responses in chicken spleen and brain tissues after infection with very virulent plus Marek's disease virus. Viral Immunol 18 1 (2005) 148-161
21. Kaiser P., Underwood G., and Davison F. Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease. J Virol 77 1 (2003) 762-768
22. Kreager K.S. Chicken industry strategies for control of tumour virus infections. Poult Sci 77 8 (1998) 1213-1216
23. Kung H.J., Xia L., Brunovskis P., Li D., Liu J.L., and Lee L.F. Meq: an MDV-specific bZIP transactivator with transforming properties. In: Hirai K. (Ed). Current topics in microbiology and immunology (2001), Springer, Berlin 245-260
24. Landman W.J.M., and Verschuren S.B.E. Titration of Marek's disease cell-associated vaccine virus (CVI 988) of reconstituted vaccine and vaccine ampoules from dutch hatcheries. Avian Dis 47 4 (2003) 1458-1465
25. Lee L.F. Macrophage restriction of Marek's disease virus replication and lymphoma proliferation. J Immunol 123 3 (1979) 1088-1091
26. Lee L.F., Sharma J.M., Nazerian K., and Witter R.L. Suppression of mitogen- induced proliferation of normal spleen cells by macrophages from chickens inoculated with Marek's disease virus. J Immunol 120 5 (1978) 1554-1559
27. Lee S.I., Ohashi K., Morimura T., Sugimoto C., and Onuma M. Re-isolation of Marek's disease virus from T cell subsets of vaccinated and non-vaccinated chickens. Arch Virol 144 1 (1999) 45-54
28. Leite-De-Moraes M.C., Hameg A., Pacilio M., Koezuka Y., Taniguchi M., Van Kaer L., et al. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J Immunol 166 2 (2001) 945-951
29. Marshall N.A., Vickers M.A., Barker R.N., and Regulatory. T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1. J Immunol 170 12 (2003) 6183-6189
30. Minang J.T., Arestrom I., Zuber B., Jonsson G., Troye-Blomberg M., and Ahlborg N. Nickel induced IL-10 down regulates Th1- but not Th2-type cytokine responses to contact allergen nickel. Clin Exp Immunol 143 3 (2006) 494-502
31. Morimura T., Ohashi K., Sugimoto C., and Onuma M. Pathogenesis of Marek's disease (MD) and possible mechanisms of immunity induced by MD vaccine. J Vet Med Sci 60 1 (1998) 1-8
32. Morimura T., Cho K.O., Kudo Y., Hiramoto Y., Ohashi K., Hattori M., et al. Anti-viral and anti-tumor effects induced by an attenuated Marek's disease virus in CD4- or CD8-deficient chickens. Arch Virol 144 9 (1999) 1809-1818
33. Nair V. Evolution of Marek's disease-a paradigm for incessant race between the pathogen and the host. Vet J 170 2 (2005) 175-183
34. Netea M.G., Kulberg B.J., Verschueren I.V., and der Meer J.W.M. Interleukin- 18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1 beta. Eur J Immunol 30 10 (2000) 3057-3060
35. Okazaki W., Purchase H.G., and Burmester B.R. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis 14 2 (1970) 413-429
36. Osterrierder N., Kamil J.P., Schumacher D., Tischer B.K., and Trapp S. Marek's disease virus: from miasma to model. Nat Rev Microbiol 4 4 (2006) 283-294
37. Quere P., Rivas C., Ester K., Novak R., and Ragland W.L. Abundance of IFN-alpha and IFN-gamma mRNA in blood of resistant and susceptible chickens infected with Marek's disease virus (MDV) or vaccinated with turkey herpesvirus; and MDV inhibition of subsequent induction of IFN gene transcription. Arch Virol 150 3 (2005) 507-519
38. Rothe H., Hausmann A., Casteels K., Okamura H., Kurimoto M., Burcart V., et al. IL-18 inhibits diabetes development in nonobese diabetic mice by counter regulation of Th1-dependent destructive insulitis. J Immunol 163 3 (1999) 1230-1236
39. Rothwell L., Young J.R., Zoorob R., Whittaker C.A., Hesketh P., Archer A., et al. Cloning and characterization of chicken IL-10 and its role in the immune response to Eimeria maxima. J Immunol 173 4 (2004) 2675-2682
40. Schat K.A., Calnek B.W., and Fabricant J. Characterization of two highly oncogenic strains of Marek's disease virus. Avian Pathol 11 4 (1982) 593-595
41. Sharma J.M., and Witter R.L. The effect of B cell immunosuppression on age related resistance of chickens to Marek's disease. Cancer Res 35 3 (1975) 711-717
42. Sharma J.M., Witter R.L., and Purchase H.G. Absence of age resistance in neonatally thymectomised chickens as evidence for cell-mediated immune surveillance in Marek's disease. Nature 253 5491 (1975) 477-479
43. Stober C.B., Lange U.G., Roberts M.T.M., Alcami A., and Blackwell J.M. IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J Immunol 175 4 (2005) 2517-2524
44. Suvas S., Azkur A.K., Kim B.S., Kumaraguru U., and Rouse B.T. CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 172 7 (2004) 4123-4132
45. Wigley P., and Kaiser P. Avian cytokines in health and disease. Rev Bras Cienc Avic 5 1 (2003) 1-14
46. Witter R.L. Increased virulence of Marek's disease virus field isolates. Avian Dis 41 1 (1997) 149-163
47. Witter R.L. The changing landscape of Marek's disease. Avian Pathol 27 Suppl. 1 (1998) S46-S53
48. Xing Z., and Schat K.A. Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures. Immunology 100 1 (2000) 70-76